These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1778314)

  • 61. Reactogenicity and immunogenicity of a double-strength acellular pertussis vaccine.
    Blumberg DA; Chatfield PC; Cherry JD; Robinson RG; Smith K; Mabie L; Holroyd HJ; Baker LR; Dudenhoeffer FE; Apau N
    Vaccine; 1992; 10(9):614-6. PubMed ID: 1502839
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An alternative temperature-based histamine-sensitisation test for absence of residual pertussis toxin in acellular pertussis vaccines.
    Jensen SE; Engelhart Illigen KE; Hasløv KR
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):73-4. PubMed ID: 20223192
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of two serological methods for potency testing of whole cell pertussis vaccines.
    von Hunolstein C; Gomez Miguel MJ; Pezzella C; Scopetti F; Behr-Gross ME; Halder M; Hoffmann S; Levels L; van der Gun J; Hendriksen C
    Pharmeuropa Bio; 2008 Dec; 2008(1):7-18. PubMed ID: 19220977
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of different detoxification procedures on the residual pertussis toxin activities in vaccines.
    Yuen CT; Asokanathan C; Cook S; Lin N; Xing D
    Vaccine; 2016 Apr; 34(18):2129-34. PubMed ID: 26973066
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The property of filamentous hemagglutinin of Bordetella pertussis].
    Chow MP; Lin CK; Lin JS; Chau WK; Ho CH; Chen SY; Lee SH; Yung CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Nov; 24(4):331-8. PubMed ID: 1845342
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies.
    Ibsen PH
    Vaccine; 1996 Apr; 14(5):359-68. PubMed ID: 8735545
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Study on toxicity of Bordetella pertussis cultures and antigens.
    Spasojević V
    Dev Biol Stand; 1977; 34():197-205. PubMed ID: 190070
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prospects for a new acellular pertussis vaccine.
    Manclark CR; Burns DL
    Ann Inst Pasteur Microbiol (1985); 1985; 136B(3):323-9. PubMed ID: 2870676
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of cyclodextrin on lipopolysaccharide production in cultures of Bordetella pertussis.
    Ibsen P; Schou C; Au-Jensen M; Heron I
    J Biol Stand; 1989 Oct; 17(4):321-30. PubMed ID: 2559082
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Single radial immunodiffusion as a method for the assay of the acellular pertussis vaccine components, pertussis toxoid, filamentous haemagglutinin and pertactin.
    Xing DK; Canthaboo C; Corbel MJ; Schild GC
    Biologicals; 1998 Sep; 26(3):217-24. PubMed ID: 10208723
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The cAMP assay: a functional in vitro alternative to the in vivo Histamine Sensitization test.
    Hoonakker ME; Ruiterkamp N; Hendriksen CF
    Vaccine; 2010 Feb; 28(5):1347-52. PubMed ID: 19941995
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Simultaneous determination of Bordetella pertussis toxin and filamentous haemagglutinin concentrations by hydroxyapatite high-performance liquid chromatography.
    Chong P; Jackson G; Cwyk W; Klein M
    J Chromatogr; 1990 Jul; 512():227-36. PubMed ID: 2172264
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Specificity and detection limit of a dermal temperature histamine sensitization test for absence of residual pertussis toxin in vaccines.
    Jensen SE; Illigen KE; Badsberg JH; Hasløv KR
    Biologicals; 2012 Jan; 40(1):36-40. PubMed ID: 22000164
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effects of purified components of Bordetella pertussis in the weight gain test for the toxicity testing of pertussis vaccines.
    Redhead K; Seagroatt V
    J Biol Stand; 1986 Jan; 14(1):57-65. PubMed ID: 2870067
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effects of different inactivating agents on the potency, toxicity and stability of pertussis vaccine.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1987 Jan; 15(1):87-98. PubMed ID: 3104344
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of formaldehyde on the toxicity and potency of pertussis vaccine.
    Gottshall RY; Nelson E; Angela F; Anderson G
    Health Lab Sci; 1975 Jan; 12(1):35-40. PubMed ID: 1053237
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Modifications of the catalytic and binding subunits of pertussis toxin by formaldehyde: effects on toxicity and immunogenicity.
    Fowler S; Xing DK; Bolgiano B; Yuen CT; Corbel MJ
    Vaccine; 2003 Jun; 21(19-20):2329-37. PubMed ID: 12744863
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Removal of lipopolysaccharide from acellular Bordetella pertussis vaccine by detergent treatment.
    Stinson RS; Lemmon RD; Baggett DW; Huff TL; Malone JA; Sloan GL; Winters AL
    J Biol Stand; 1986 Oct; 14(4):261-71. PubMed ID: 2881930
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Effect of solution environment on the purification of pertussis toxin].
    Wu T; Bi J; Huang Y; Zhang Y; Sun L; Sun C; Su Z
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1279-84. PubMed ID: 18837409
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An international collaborative study of the effect of active pertussis toxin on the modified Kendrick test for acellular pertussis vaccines.
    Xing D; Gaines Das R; Douglas-Bardsley A; Asokanathan C; Corbel M
    Biologicals; 2014 Mar; 42(2):101-8. PubMed ID: 24388289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.